BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 1674365)

  • 1. c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.
    Ponzetto C; Giordano S; Peverali F; Della Valle G; Abate ML; Vaula G; Comoglio PM
    Oncogene; 1991 Apr; 6(4):553-9. PubMed ID: 1674365
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression of truncated transcripts of the proto-oncogene c-fps/fes in human lymphoma and lymphoid leukemia cell lines.
    Jücker M; Roebroek AJ; Mautner J; Koch K; Eick D; Diehl V; Van de Ven WJ; Tesch H
    Oncogene; 1992 May; 7(5):943-52. PubMed ID: 1373879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tyrosine kinase receptor indistinguishable from the c-met protein.
    Giordano S; Ponzetto C; Di Renzo MF; Cooper CS; Comoglio PM
    Nature; 1989 May; 339(6220):155-6. PubMed ID: 2541345
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Identification of mutations in the coding sequence of the proto-oncogene c-kit in a human mast cell leukemia cell line causing ligand-independent activation of c-kit product.
    Furitsu T; Tsujimura T; Tono T; Ikeda H; Kitayama H; Koshimizu U; Sugahara H; Butterfield JH; Ashman LK; Kanayama Y
    J Clin Invest; 1993 Oct; 92(4):1736-44. PubMed ID: 7691885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protein kinase-c activation inhibits tyrosine phosphorylation of the c-met protein.
    Gandino L; Di Renzo MF; Giordano S; Bussolino F; Comoglio PM
    Oncogene; 1990 May; 5(5):721-5. PubMed ID: 2111905
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The human met oncogene is a member of the tyrosine kinase family.
    Gonzatti-Haces M; Park M; Dean M; Blair DG; Vande Woude GF
    Princess Takamatsu Symp; 1986; 17():221-32. PubMed ID: 3332011
    [TBL] [Abstract][Full Text] [Related]  

  • 7. c-erbB3 gene encodes secreted as well as transmembrane receptor tyrosine kinase.
    Katoh M; Yazaki Y; Sugimura T; Terada M
    Biochem Biophys Res Commun; 1993 May; 192(3):1189-97. PubMed ID: 7685162
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A novel germ line juxtamembrane Met mutation in human gastric cancer.
    Lee JH; Han SU; Cho H; Jennings B; Gerrard B; Dean M; Schmidt L; Zbar B; Vande Woude GF
    Oncogene; 2000 Oct; 19(43):4947-53. PubMed ID: 11042681
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autophosphorylation modulates the kinase activity and oncogenic potential of the Met receptor tyrosine kinase.
    Rodrigues GA; Park M
    Oncogene; 1994 Jul; 9(7):2019-27. PubMed ID: 8208547
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Structure, biosynthesis and biochemical properties of the HGF receptor in normal and malignant cells.
    Comoglio PM
    EXS; 1993; 65():131-65. PubMed ID: 8380735
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of rearranged Tpr-met mRNA expression in human gastric cancer cell lines and gastric mucosa and carcinoma.
    Osaki M; Miyata H; Hayashi A; Gomyo Y; Tatebe S; Ito H
    Anticancer Res; 1996; 16(5A):2881-4. PubMed ID: 8917402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.
    Naldini L; Vigna E; Narsimhan RP; Gaudino G; Zarnegar R; Michalopoulos GK; Comoglio PM
    Oncogene; 1991 Apr; 6(4):501-4. PubMed ID: 1827664
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Biosynthesis of the protein encoded by the c-met proto-oncogene.
    Giordano S; Di Renzo MF; Narsimhan RP; Cooper CS; Rosa C; Comoglio PM
    Oncogene; 1989 Nov; 4(11):1383-8. PubMed ID: 2554238
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gastric cancer cell line Hs746T harbors a splice site mutation of c-Met causing juxtamembrane domain deletion.
    Asaoka Y; Tada M; Ikenoue T; Seto M; Imai M; Miyabayashi K; Yamamoto K; Yamamoto S; Kudo Y; Mohri D; Isomura Y; Ijichi H; Tateishi K; Kanai F; Ogawa S; Omata M; Koike K
    Biochem Biophys Res Commun; 2010 Apr; 394(4):1042-6. PubMed ID: 20331976
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vitro and in vivo expressions of transforming growth factor-alpha and tyrosine kinase receptors in human non-small-cell lung carcinomas.
    Liu C; Tsao MS
    Am J Pathol; 1993 Apr; 142(4):1155-62. PubMed ID: 8097369
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Nucleotide sequence and expression of a novel human receptor-type tyrosine kinase gene (flt) closely related to the fms family.
    Shibuya M; Yamaguchi S; Yamane A; Ikeda T; Tojo A; Matsushime H; Sato M
    Oncogene; 1990 Apr; 5(4):519-24. PubMed ID: 2158038
    [TBL] [Abstract][Full Text] [Related]  

  • 17. c-Met is a potentially new therapeutic target for treatment of human melanoma.
    Puri N; Ahmed S; Janamanchi V; Tretiakova M; Zumba O; Krausz T; Jagadeeswaran R; Salgia R
    Clin Cancer Res; 2007 Apr; 13(7):2246-53. PubMed ID: 17404109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Primary structure of the met protein tyrosine kinase domain.
    Chan AM; King HW; Tempest PR; Deakin EA; Cooper CS; Brookes P
    Oncogene; 1987 May; 1(2):229-33. PubMed ID: 3325883
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Analysis of structure and activation of some receptor-type tyrosine kinase oncogenes.
    Shibuya M; Matsushime H; Yamazaki H; Wang LH; Fukui Y; Ueyama Y; Tamaoki N
    Princess Takamatsu Symp; 1986; 17():195-202. PubMed ID: 3455414
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characterization of the murine Mpl proto-oncogene, a member of the hematopoietic cytokine receptor family: molecular cloning, chromosomal location and evidence for a function in cell growth.
    Vigon I; Florindo C; Fichelson S; Guenet JL; Mattei MG; Souyri M; Cosman D; Gisselbrecht S
    Oncogene; 1993 Oct; 8(10):2607-15. PubMed ID: 8397366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.